APA (7th ed.) Citation

Madle, M., Krämer, I., Giesen, N., Schwarzbich, M., Wuchter, P., Herfarth, K., . . . Witzens-Harig, M. (2015). The influence of rituximab, high-dose therapy followed by autologous stem cell transplantation, and age in patients with primary CNS lymphoma. Annals of hematology, 94(11), . https://doi.org/10.1007/s00277-015-2470-4

Chicago Style (17th ed.) Citation

Madle, Michael, Ines Krämer, Nicola Giesen, Mark-Alexander Schwarzbich, Patrick Wuchter, Klaus Herfarth, Gerlinde Egerer, Anthony Dick Ho, and Mathias Witzens-Harig. "The Influence of Rituximab, High-dose Therapy Followed by Autologous Stem Cell Transplantation, and Age in Patients with Primary CNS Lymphoma." Annals of Hematology 94, no. 11 (2015). https://doi.org/10.1007/s00277-015-2470-4.

MLA (9th ed.) Citation

Madle, Michael, et al. "The Influence of Rituximab, High-dose Therapy Followed by Autologous Stem Cell Transplantation, and Age in Patients with Primary CNS Lymphoma." Annals of Hematology, vol. 94, no. 11, 2015, https://doi.org/10.1007/s00277-015-2470-4.